CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
7.94
-0.25 (-3.05%)
At close: Jul 22, 2026, 4:00 PM EDT
7.85
-0.09 (-1.13%)
Pre-market: Jul 23, 2026, 4:25 AM EDT
CorMedix Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, CorMedix stock has a consensus rating of "Buy" and an average price target of $15. The average 1-year stock price forecast is 88.92% higher than the current stock price, while the lowest is $13 (+63.73%) and the highest is $19 (+139.29%).
Price Target: $15 (+88.92%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CorMedix stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $14 → $13 | Buy | Maintains | $14 → $13 | +63.73% | Jul 7, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $14 → $15 | Buy | Reiterates | $14 → $15 | +88.92% | May 15, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 15, 2026 |
| Needham | Needham | Buy Maintains $15 | Buy | Maintains | $15 | +88.92% | May 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $13 | Buy | Reiterates | $13 | +63.73% | May 14, 2026 |
Financial Forecast
Revenue This Year
334.57M
from 311.71M
Increased by 7.33%
Revenue Next Year
285.22M
from 334.57M
Decreased by -14.75%
EPS This Year
0.97
from 2.15
Decreased by -54.80%
EPS Next Year
0.35
from 0.97
Decreased by -63.92%
EPS and Forward PE are based on non-GAAP adjusted numbers.